Tuesday, Jan 9, 2024 · SEC filings

What the smart money revealed on Jan 9

Real insider buys23insiders · $665K
Real insider sales52insiders · $69.4M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

523 insider filings came in. We hid 68 planned (10b5-1) sellers and 365 people whose filings were routine, like grants and tax withholding.

trending_up

Starwood Credit Real Estate Income Trust Director John McCarthy bought $300K

14,977 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 2
$300K
trending_up

Fortress Biotech (FBIO) President Lindsay Rosenwald bought $119K

50,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 5 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 5 beat Traded Jan 5
$119K
trending_down

AutoZone (AZO) COO Thomas Newbern sold $19.9M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 2,519 shares directly.

Real sale Form 4 Traded Jan 5
$19.9M
trending_down

Intuit (INTU) EVP Laura Fennell sold $17.6M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 100,059 shares directly.

Real sale Form 4 Traded Jan 5–8
$17.6M
trending_down

VOXX International (VOXX) President Beat Kahli sold $15.7M

Not marked as a planned 10b5-1 sale. Sold 33% of the shares they held directly. Still holds 3.13M shares.

Real sale Form 4 Sold 33% of stake Traded Jan 5
$15.7M
Show 21 more real buys
GAM General American Investors · President and CEO Jeffrey Priest · Traded Jan 8
$42.2K
DHY Credit Suisse High Yield Bond Fund · Trustee Laura DeFelice · Traded Jan 8
$19.8K
WAST Metaworks Platforms · President Scott Gallagher · Traded Jan 6
$18.4K
ZSQR Coeptis Therapeutics · CEO and President David Mehalick · Traded Jan 5–8
$16.7K
CIK Credit Suisse Asset Management Income Fund · Chair of the Board Laura DeFelice · Traded Jan 8
$16.1K
ERC Allspring Multi-Sector Income Fund · Director William Ebsworth · Traded Jan 9
$14.2K
NMRD Nemaura Medical · COO Arash Ghadar-Ghadr · Traded Jan 5
$14K
ERH Allspring Utilities & High Income Fund · Director William Ebsworth · Traded Jan 9
$13.2K
EAD Allspring Income Opportunities Fund · Director William Ebsworth · Traded Jan 9
$13.2K
EOD Allspring Global Dividend Opportunity Fund · Director William Ebsworth · Traded Jan 9
$13K
CZNC Citizens & Northern · Director Frank Pellegrino · Traded Jan 5
$9.86K
CZNC Citizens & Northern · Director Katherine Shattuck · Traded Jan 5
$8.25K
ZSQR Coeptis Therapeutics · Director Gene Salkind · Traded Jan 5
$8K
ZSQR Coeptis Therapeutics · VP of Operations Daniel Yerace · Traded Jan 5
$7.49K
VANI Vivani Medical · Director Gregg Williams · Traded Jan 8
$7.27K
CSBR Champions Oncology · Director Daniel Mendelson · Traded Jan 8
$6.15K
ZSQR Coeptis Therapeutics · Director Christopher Cochran · Traded Jan 5
$5.39K
ALZN Alzamend Neuro · Director Milton Ault III · Traded Jan 5
$5.1K
CZNC Citizens & Northern · Director Robert Loughery · Traded Jan 5
$4.98K
HQH abrdn Healthcare Investors · Vice President Alan Goodson · Traded Dec 21 · Filed late
$2.74K
RCG RENN Fund · President and CEO Murray Stahl · Traded Jan 8
$124
Show 49 more real sales
AVGO Broadcom · CFO and Chief Accounting Officer Kirsten Spears · Traded Jan 5
$2.61M
WDAY Workday · Co-President Sayan Chakraborty · Traded Jan 5–8
$2.08M
TEAM Atlassian · Co-CEO Michael Cannon-Brookes · Traded Jan 8
$1.93M
TEAM Atlassian · Co-CEO Scott Farquhar · Traded Jan 8
$1.93M
WDAY Workday · CFO Zane Rowe · Traded Jan 5
$1.24M
WDAY Workday · COO James Bozzini · Traded Jan 5
$1.16M
WDAY Workday · Co-CEO Aneel Bhusri · Traded Jan 5
$887K
WDAY Workday · Co-President Douglas Robinson · Traded Jan 5
$689K
DRI Darden Restaurants · SVP John Madonna · Traded Jan 8
$628K
LEGH Legacy Housing · Director Curtis Hodgson · Traded Jan 8–9
$414K
DNLI Denali Therapeutics · President and CEO Ryan Watts · Traded Jan 5
$340K
S SentinelOne · COO Narayanan Srivatsan · Traded Jan 8
$223K
DNLI Denali Therapeutics · Chief Medical Officer Carole Ho · Traded Jan 5
$194K
DNLI Denali Therapeutics · COFO and Secretary Alexander Schuth · Traded Jan 5
$194K
ANAB Anaptysbio · CEO Daniel Faga · Traded Jan 8
$150K
IMVT Immunovant · CEO Peter Salzmann · Traded Jan 5
$148K
MIRM Mirum Pharmaceuticals · President and CEO Christopher Peetz · Traded Jan 8
$146K
MRTX Mirati Therapeutics · EVP Benjamin Hickey · Traded Jan 8
$123K
ACAD Acadia Pharmaceuticals · CEO Stephen Davis · Traded Jan 8
$112K
CRNC Cerence · EVP Iqbal Arshad · Traded Jan 9
$97.5K
CRNC Cerence · EVP Thomas Beaudoin · Traded Jan 9
$97.4K
BFLY Butterfly Network · EVP Heather Getz · Traded Jan 5
$67.5K
BB Blackberry · CFO Steve Rai · Traded Jan 8
$65.2K
DNLI Denali Therapeutics · Director Steve Krognes · Traded Jan 5
$62.3K
BB Blackberry · CEO and President John Giamatteo · Traded Jan 8
$59K
ANAB Anaptysbio · Chief Medical Officer Paul Lizzul · Traded Jan 8
$55.7K
OLP One Liberty Properties · COO Justin Clair · Traded Jan 8
$55.4K
ANAB Anaptysbio · Chief Legal Officer Eric Loumeau · Traded Jan 8
$50.3K
IMVT Immunovant · Chief Development Officer Julia Butchko · Traded Jan 5
$50.1K
ANAB Anaptysbio · CFO Dennis Mulroy · Traded Jan 8
$47.5K
BB Blackberry · President of IoT Mattias Eriksson · Traded Jan 8
$44.8K
MIRM Mirum Pharmaceuticals · Head of Research and Development Pamela Vig · Traded Jan 8
$39.5K
MIRM Mirum Pharmaceuticals · COO Peter Radovich · Traded Jan 8
$39.5K
BFLY Butterfly Network · CTO Andrei Stoica · Traded Jan 5
$36.3K
MIRM Mirum Pharmaceuticals · Chief Development Officer Lara Longpre · Traded Jan 8
$28.6K
KEQU Kewaunee Scientific · VP of Manufacturing Operations Douglas Batdorff · Traded Jan 8
$26.2K
FIGS FIGS · CFO Daniella Turenshine · Traded Jan 5
$25.5K
ACAD Acadia Pharmaceuticals · EVP Brendan Teehan · Traded Jan 8
$21.9K
BB Blackberry · Chief Gv Aff and Pub Pol Officer Marjorie Dickman · Traded Jan 8
$18.6K
ACAD Acadia Pharmaceuticals · EVP Austin Kim · Traded Jan 8
$17.7K
MIRM Mirum Pharmaceuticals · SVP Jolanda Howe · Traded Jan 8
$14.8K
RUN Sunrun · CFO Danny Abajian · Traded Jan 8
$8.76K
TSVT 2seventy bio · President and CEO Nick Leschly · Traded Jan 5
$5.83K
TSVT 2seventy bio · COO William Baird III · Traded Jan 5
$5.17K
NXU Nxu · Interim CFO Sarah Wyant · Traded Dec 31
$4.77K
RUN Sunrun · Chief Revenue Officer Paul Dickson · Traded Jan 8
$4.11K
QXO SilverSun Technologies · Director John Schachtel · Traded Jan 5
$3.09K
TSVT 2seventy bio · Chief Scientific Officer Philip Gregory · Traded Jan 5
$2.98K
VSTM Verastem · CFO Daniel Calkins · Traded Jan 5
$51

13F season

Holdings as of Dec 31, 2023 are due Feb 14

49 funds have filed so far. 40 filed for the quarter before.

Biggest real insider buys, Jan 3–9

Open-market buys by officers and directors, filed in the 7 days up to Jan 9.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist